118 related articles for article (PubMed ID: 38253083)
1. Anti-NOTCH1 therapy with OMP-52 M51 inhibits salivary adenoid cystic carcinoma by depressing epithelial-mesenchymal transition (EMT) process and inducing ferroptosis.
Li R; Hu Z; Qiao Q; Zhou D; Sun M
Toxicol Appl Pharmacol; 2024 Mar; 484():116825. PubMed ID: 38253083
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-β and epithelial-mesenchymal transition are associated with pulmonary metastasis in adenoid cystic carcinoma.
Dong L; Ge XY; Wang YX; Yang LQ; Li SL; Yu GY; Gao Y; Fu J
Oral Oncol; 2013 Nov; 49(11):1051-8. PubMed ID: 23962790
[TBL] [Abstract][Full Text] [Related]
3. Epithelial mesenchymal transition is required for acquisition of anoikis resistance and metastatic potential in adenoid cystic carcinoma.
Jia J; Zhang W; Liu JY; Chen G; Liu H; Zhong HY; Liu B; Cai Y; Zhang JL; Zhao YF
PLoS One; 2012; 7(12):e51549. PubMed ID: 23272116
[TBL] [Abstract][Full Text] [Related]
4. The NOTCH1-HEY1 pathway regulates self-renewal and epithelial-mesenchymal transition of salivary adenoid cystic carcinoma cells.
Xie J; Lin LS; Huang XY; Gan RH; Ding LC; Su BH; Zhao Y; Lu YG; Zheng DL
Int J Biol Sci; 2020; 16(4):598-610. PubMed ID: 32025208
[TBL] [Abstract][Full Text] [Related]
5. Concomitant inhibition of epidermal growth factor and vascular endothelial growth factor receptor tyrosine kinases reduces growth and metastasis of human salivary adenoid cystic carcinoma in an orthotopic nude mouse model.
Younes MN; Park YW; Yazici YD; Gu M; Santillan AA; Nong X; Kim S; Jasser SA; El-Naggar AK; Myers JN
Mol Cancer Ther; 2006 Nov; 5(11):2696-705. PubMed ID: 17121916
[TBL] [Abstract][Full Text] [Related]
6. C-kit induces epithelial-mesenchymal transition and contributes to salivary adenoid cystic cancer progression.
Tang YL; Fan YL; Jiang J; Li KD; Zheng M; Chen W; Ma XR; Geng N; Chen QM; Chen Y; Liang XH
Oncotarget; 2014 Mar; 5(6):1491-501. PubMed ID: 24721839
[TBL] [Abstract][Full Text] [Related]
7. Activating NOTCH1 Mutations Define a Distinct Subgroup of Patients With Adenoid Cystic Carcinoma Who Have Poor Prognosis, Propensity to Bone and Liver Metastasis, and Potential Responsiveness to Notch1 Inhibitors.
Ferrarotto R; Mitani Y; Diao L; Guijarro I; Wang J; Zweidler-McKay P; Bell D; William WN; Glisson BS; Wick MJ; Kapoun AM; Patnaik A; Eckhardt G; Munster P; Faoro L; Dupont J; Lee JJ; Futreal A; El-Naggar AK; Heymach JV
J Clin Oncol; 2017 Jan; 35(3):352-360. PubMed ID: 27870570
[TBL] [Abstract][Full Text] [Related]
8. Expression of ERBB3 binding protein 1 (EBP1) in salivary adenoid cystic carcinoma and its clinicopathological relevance.
Sun J; Luo Y; Tian Z; Gu L; Xia SC; Yu Y
BMC Cancer; 2012 Oct; 12():499. PubMed ID: 23110497
[TBL] [Abstract][Full Text] [Related]
9. Diffuse Staining for Activated NOTCH1 Correlates With NOTCH1 Mutation Status and Is Associated With Worse Outcome in Adenoid Cystic Carcinoma.
Sajed DP; Faquin WC; Carey C; Severson EA; H Afrogheh A; A Johnson C; Blacklow SC; Chau NG; Lin DT; Krane JF; Jo VY; Garcia JJ; Sholl LM; Aster JC
Am J Surg Pathol; 2017 Nov; 41(11):1473-1482. PubMed ID: 28914715
[TBL] [Abstract][Full Text] [Related]
10. NOTCH1 signaling contributes to cell growth, anti-apoptosis and metastasis in salivary adenoid cystic carcinoma.
Su BH; Qu J; Song M; Huang XY; Hu XM; Xie J; Zhao Y; Ding LC; She L; Chen J; Lin LS; Lin X; Zheng DL; Lu YG
Oncotarget; 2014 Aug; 5(16):6885-95. PubMed ID: 25149541
[TBL] [Abstract][Full Text] [Related]
11. EGF/EGFR Promotes Salivary Adenoid Cystic Carcinoma Cell Malignant Neural Invasion
Ren Y; Hong Y; He W; Liu Y; Chen W; Wen S; Sun M
Curr Cancer Drug Targets; 2022; 22(7):603-616. PubMed ID: 35410600
[TBL] [Abstract][Full Text] [Related]
12. Increased retinoic acid signaling decreases lung metastasis in salivary adenoid cystic carcinoma by inhibiting the noncanonical Notch1 pathway.
Zhou MJ; Yang JJ; Ma TY; Feng GX; Wang XL; Wang LY; Ge YZ; Gao R; Liu HL; Shan L; Kong L; Chen XH
Exp Mol Med; 2023 Mar; 55(3):597-611. PubMed ID: 36879115
[TBL] [Abstract][Full Text] [Related]
13. Thioredoxin 1 mediates TGF-β-induced epithelial-mesenchymal transition in salivary adenoid cystic carcinoma.
Jiang Y; Feng X; Zheng L; Li SL; Ge XY; Zhang JG
Oncotarget; 2015 Sep; 6(28):25506-19. PubMed ID: 26325518
[TBL] [Abstract][Full Text] [Related]
14. PRRX1-induced epithelial-to-mesenchymal transition in salivary adenoid cystic carcinoma activates the metabolic reprogramming of free fatty acids to promote invasion and metastasis.
Jiang YP; Tang YL; Wang SS; Wu JS; Zhang M; Pang X; Wu JB; Chen Y; Tang YJ; Liang XH
Cell Prolif; 2020 Jan; 53(1):e12705. PubMed ID: 31657086
[TBL] [Abstract][Full Text] [Related]
15. BRD4 inhibition suppresses cell growth, migration and invasion of salivary adenoid cystic carcinoma.
Wang L; Wu X; Wang R; Yang C; Li Z; Wang C; Zhang F; Yang P
Biol Res; 2017 May; 50(1):19. PubMed ID: 28545522
[TBL] [Abstract][Full Text] [Related]
16. BDNF mediated TrkB activation contributes to the EMT progression and the poor prognosis in human salivary adenoid cystic carcinoma.
Jia S; Wang W; Hu Z; Shan C; Wang L; Wu B; Yang Z; Yang X; Lei D
Oral Oncol; 2015 Jan; 51(1):64-70. PubMed ID: 25456007
[TBL] [Abstract][Full Text] [Related]
17. Sulforaphane induces G2-M arrest and apoptosis in high metastasis cell line of salivary gland adenoid cystic carcinoma.
Chu WF; Wu DM; Liu W; Wu LJ; Li DZ; Xu DY; Wang XF
Oral Oncol; 2009 Nov; 45(11):998-1004. PubMed ID: 19589718
[TBL] [Abstract][Full Text] [Related]
18. Newly Identified Members of FGFR1 Splice Variants Engage in Cross-talk with AXL/AKT Axis in Salivary Adenoid Cystic Carcinoma.
Humtsoe JO; Kim HS; Leonard B; Ling S; Keam B; Marchionni L; Afsari B; Considine M; Favorov AV; Fertig EJ; Kang H; Ha PK
Cancer Res; 2021 Feb; 81(4):1001-1013. PubMed ID: 33408119
[TBL] [Abstract][Full Text] [Related]
19. Dll4/Notch1 signalling pathway is required in collective invasion of salivary adenoid cystic carcinoma.
Wang K; Fan HY; Pang X; Zhang M; Yu XH; Wu JS; Chen BJ; Jiang J; Liang XH; Tang YL
Oncol Rep; 2021 Mar; 45(3):1011-1022. PubMed ID: 33469672
[TBL] [Abstract][Full Text] [Related]
20. Mammalian target of rapamycin pathway promotes tumor-induced angiogenesis in adenoid cystic carcinoma: its suppression by isoliquiritigenin through dual activation of c-Jun NH2-terminal kinase and inhibition of extracellular signal-regulated kinase.
Sun ZJ; Chen G; Zhang W; Hu X; Huang CF; Wang YF; Jia J; Zhao YF
J Pharmacol Exp Ther; 2010 Aug; 334(2):500-12. PubMed ID: 20484154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
